Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:30:11 EDT Tue 09 Jun 2026
Enter Symbol
or Name
USA
CA



Q:FOLD - AMICUS THERAPEUTICS INC - https://www.amicustherapeutics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
FOLD - QHALTED14.49    14.48  5.51Apr 24Feb 2015 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-20 16:01U:FOLDNews ReleaseAmicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
2026-02-03 08:00U:FOLDNews ReleaseAmicus Therapeutics Presents New Long-term Data for both Galafold(TM) (migalastat) and POMBILITI(TM) (cipaglucosidase alfa-atga) + OPFOLDA(TM) (miglustat) at the 22nd Annual WORLDSymposium(TM) 2026
2025-12-19 07:45U:FOLDNews ReleaseBioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
2025-11-04 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate Updates
2025-10-31 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in November 2025
2025-10-23 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025
2025-09-08 09:00U:FOLDNews ReleaseNew 4-Year Data for Pombiliti(TM) (cipaglucosidase alfa-atga) + Opfolda(TM) (miglustat) Presented at ICIEM
2025-08-29 07:00U:FOLDNews ReleaseAmicus Therapeutics to Present at Upcoming Investor Conferences in September 2025
2025-07-31 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Second Quarter 2025 Financial Results and Corporate Updates
2025-07-21 07:00U:FOLDNews ReleaseAmicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025
2025-06-25 07:00U:FOLDNews ReleaseAmicus Therapeutics Announces Approval of Pombiliti(TM) (cipaglucosidase alfa) + Opfolda(TM) (miglustat) in Japan